Research Article
Semiannual Imaging Surveillance Is Associated with Better Survival
in Patients with Non-B, Non-C Hepatocellular Carcinoma
Table 2
Univariate and multivariate analysis for variables associated with survival.
| Variable | | Univariate analysis | Multivariate analysis | HR | 95% CI | value | HR | 95% CI | value |
| Age (years) | | | | | | | | ≥71 | 97 | 1.66 | 0.67–4.09 | 0.27 | | | | ≤70 | 74 | | | | | | | Gender | | | | | | | | M | 118 | 3.43 | 0.79–14.86 | 0.08 | | | | F | 53 | | | | | | | Etiology | | | | | | | | NBNC | 30 | 6.26 | 2.54–15.45 | <0.01 | 4.32 | 1.46–12.8 | <0.01 | B/C | 141 | | | | | | | Child-Pugh | | | | | | | | B, C | 30 | 2.02 | 0.82–4.98 | 0.13 | | | | A | 141 | | | | | | | Platelet (/mL) | | | | | | | | ≤12.0 × 104 | 104 | 0.81 | 0.32–2.02 | 0.65 | | | | ≥12.1 × 104 | 67 | | | | | | | ALT (IU/L) | | | | | | | | ≥40 | 65 | 1.08 | 0.43–2.70 | 0.87 | | | | ≤39 | 106 | | | | | | | AFP (ng/mL) | | | | | | | | ≥20.1 | 74 | 1.66 | 0.67–4.10 | 0.27 | | | | ≤20.0 | 97 | | | | | | | DCP (mAU/mL) | | | | | | | | ≥40 | 60 | 3.08 | 1.23–7.69 | 0.02 | 1.14 | 0.39–3.32 | 0.82 | ≤39 | 106 | | | | | | | AFP-L3 (%) | | | | | | | | ≥10.0 | 34 | 2.85 | 1.12–7.27 | 0.03 | 1.80 | 0.62–5.22 | 0.28 | ≤9.9 | 137 | | | | | | | HCC stage (TNM) | | | | | | | | III, IV | 45 | 3.94 | 1.58–9.81 | <0.01 | 1.48 | 0.50–4.31 | 0.48 | I, II | 136 | | | | | | | Semiannual surveillance | | | | | | | | No | 73 | 6.84 | 1.98–23.64 | <0.01 | 4.55 | 1.21–17.08 | 0.02 | Yes | 98 | | | | | | | Curative therapy | | | | | | | | No | 56 | 8.71 | 2.88–26.33 | <0.01 | 5.93 | 1.88–18.67 | <0.01 | Yes | 115 | | | | | | |
|
|
Curative therapy includes operative resection and radiofrequency ablation.
|